Please login to the form below

Not currently logged in
Email:
Password:

Cerenis appoints Dr John Paolini as chief medical officer

He will be responsible for the strategic planning and execution of the biopharmaceutical company's clinical trials

Dr John Paolini has joined biopharmaceutical company Cerenis as chief medical officer.

Dr Paolini comes to the Toulouse, France and Ann Arbor, US-based company with 15 years clinical and research experience, notably at Merck & Co and Bayer Healthcare Pharmaceuticals.

At Cerenis he will be responsible for the strategic planning and execution of the clinical trials for the company's portfolio of novel cardiovascular therapies, including lead product CER-001, which is currently being studied for acute coronary syndrome.

“The appointment of Dr Paolini comes at a crucial time in our development, with our lead drug candidate, CER-001 in phase II; this product addresses a significant unmet medical need and represents a multibillion dollar opportunity,” said Jean-Louis Dasseux, CEO of Cerenis.

29th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics